Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

ZymoGenetics, Inc.(ZGEN)

 
123Jump Rating: - Avoid   Underwriters: Lehman Brothers
      Merrill Lynch & Co.
Status: Priced   Bear Stearns & Co. Inc.
 
Address: 1201 Eastlake Ave. East Seattle,
 FiledDate: 09/10/2001
     
  Filed Price Range ($): $16.00-18.00
       
Telephone: 206-442-6600 Filed Offer Amount ($ Million): $120.00
       
Fax: 206-442-6608 Shares Offered (Millions): 10
       
Websites: www.zymogenetics.com Shares Outstanding (Millions):
       
Management: Bruce Carter, Chair./Pres./CEO
 IPO Date: 01/31/2002
  James Johnson, SVP/CFO
    
  Fredrik Henell, SVP
 Final Offer Price ($): $12.00
       
Industry: Pharmaceuticals Final Offer Size (Millions of Shares): 0.00
       
Employees: 468 Final Offer Amount ($ Million): $0.00
       
Competitors: CuraGen
 S-1 Forms:
  Genentech
    
  Human Genome Sciences
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Investor Relations Corporate / History Profile Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1996 64387 55658 8729 3394 4614 1.41
1997 67679 62736 4943 895 4260 1.3
1998 66744 59225 7519 1273 5718 1.75
1999 69675 57965 11710 2454 9422 2.88
2000 32464 61406 -28942 5893 -30377 -12.17
2001 8550 28653 -20103 0.00 -15896 -8
* Six Months ended June 2001
 
 
© 1999-2008 123jump.com. All rights reserved